Finance

Lists
Why is AKUMS down ၂.၅၁%?
Dive Deeper
AKUMS:NSE
Akums Drugs and Pharmaceuticals Ltd
၇၃၁.၀၀ ₹
-၂.၅၁%
(-၁၈.၈၀) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AKUMS...
Open
၇၄၉.၈၀ ₹
High
၇၅၂.၈၀ ₹
Low
၇၂၈.၇၀ ₹
Mkt. cap
ဋေ ၁.၁၂ သ
Avg. vol.
၂.၇၂ သိန်း
Volume
၁.၅၁ သိန်း
Dividend
၀.၁၄%
Quarterly dividend
၀.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၃
P/E ratio
၃၈.၃၈
52-wk high
၈၃၈.၈၀ ₹
52-wk low
၄၀၉.၃၀ ₹
EPS
၁၉.၀၅ ₹
No. of employees
၇ ထောင်
Open
၇၄၉.၈၀ ₹
High
၇၅၂.၈၀ ₹
Low
၇၂၈.၇၀ ₹
Mkt. cap
ဋေ ၁.၁၂ သ
Avg. vol.
၂.၇၂ သိန်း
Volume
၁.၅၁ သိန်း
Dividend
၀.၁၄%
Quarterly dividend
၀.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၃
P/E ratio
၃၈.၃၈
52-wk high
၈၃၈.၈၀ ₹
52-wk low
၄၀၉.၃၀ ₹
EPS
၁၉.၀၅ ₹
No. of employees
၇ ထောင်
News stories
From web sources and news partners
FOREX.com
FOREX.com
·
ပြီးခဲ့သည့် ၃၅ မိနစ်
S&P 500, Nasdaq, Dow and Russell 2000 For the Week Ahead
MarketWatch
MarketWatch
·
ပြီးခဲ့သည့် ၁ ရက်
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၁ နာရီ
Futures: Nasdaq Breaks Support; What To Do Now
Profile
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024. Wikipedia
About Akums Drugs and Pharmaceuticals Ltd
CEO-
Employees၇.၃၄ ထောင်
Founded၂၀၀၄
Headquarters-
Sector-
Websiteakums.in
Last report
၂၀၂၆ ဩ ၁၀
Fiscal period
Q1 2027
၆.၅၃ ₹ / ၆.၁၀ ₹
+၇.၀၅%beat
Revenue / Est. (INR)
ဋေ ၁.၁၇ ထ / ဋေ ၁.၁၆ ထ
+၀.၁၄%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၁.၀၂ ထ
ဋေ ၁.၁၆ ထ
ဋေ ၁.၁၆ ထ
ဋေ ၁.၁၇ ထ
Cost of goods sold
၅၉၂.၅၆ ဋေ
၆၇၈.၅၈ ဋေ
၇၃၆.၆၇ ဋေ
၆၄၅.၄၂ ဋေ
Cost of revenue
၅၉၂.၅၆ ဋေ
၆၇၈.၅၈ ဋေ
၇၃၆.၆၇ ဋေ
၆၄၅.၄၂ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၈၉.၂၇ ဋေ
၁၈၉.၃၈ ဋေ
၂၃၇.၂၉ ဋေ
၂၀၁.၄၃ ဋေ
Operating expense
၃၆၈.၃၆ ဋေ
၃၇၃.၈၀ ဋေ
၃၀၉.၄၀ ဋေ
၃၈၇.၅၉ ဋေ
Total operating expenses
၉၆၀.၉၂ ဋေ
ဋေ ၁.၀၅ ထ
ဋေ ၁.၀၅ ထ
ဋေ ၁.၀၃ ထ
Operating income
၅၆.၆၁ ကုဋေ
၁၀၇.၂၁ ဋေ
၁၁၄.၁၉ ဋေ
၁၃၃.၆၁ ဋေ
Other non operating income
၃၂.၃၆ ကုဋေ
၃၄.၃၃ ကုဋေ
-၉၄.၂၁ ကုဋေ
၃၀.၃၈ ကုဋေ
EBT including unusual items
၆၅.၆၇ ကုဋေ
၉၉.၅၇ ကုဋေ
၁၂၁.၂၂ ဋေ
၁၃၉.၂၄ ဋေ
EBT excluding unusual items
၆၅.၆၇ ကုဋေ
၁၁၇.၇၉ ဋေ
၁၁၉.၂၀ ဋေ
၁၃၉.၂၄ ဋေ
Income tax expense
၂၂.၉၈ ကုဋေ
၃၁.၈၉ ကုဋေ
၃၉.၈၇ ကုဋေ
၃၈.၂၆ ကုဋေ
Effective tax rate
၃၄.၉၉%
၃၂.၀၃%
၃၂.၈၉%
၂၇.၄၈%
Other operating expenses
၁၄၁.၂၂ ဋေ
၁၄၄.၇၇ ဋေ
၃၁.၉၉ ကုဋေ
၁၄၅.၁၀ ဋေ
Net income
၄၀.၇၈ ကုဋေ
၆၆.၃၂ ကုဋေ
၈၄.၆၁ ကုဋေ
၁၀၀.၀၁ ဋေ
Net profit margin
၄.၀၁%
၅.၇၂%
၇.၂၉%
၈.၅၇%
Earnings per share
၂.၆၆
၅.၁၄
-
၆.၅၃
Interest and investment income
-
-
၁၀၉.၆၈ ဋေ
-
Interest expense
-၂၃.၃၀ ကုဋေ
-၂၃.၇၄ ကုဋေ
-၁၈.၄၄ ကုဋေ
-၂၄.၇၆ ကုဋေ
Net interest expenses
-၂၃.၃၀ ကုဋေ
-၂၃.၇၄ ကုဋေ
၉၁.၂၄ ကုဋေ
-၂၄.၇၆ ကုဋေ
Depreciation and amortization charges
၃၇.၈၆ ကုဋေ
၃၉.၆၅ ကုဋေ
၄၀.၁၂ ကုဋေ
၄၁.၀၆ ကုဋေ
EBITDA
၉၄.၀၀ ကုဋေ
၁၄၁.၇၉ ဋေ
၁၄၉.၃၁ ဋေ
၁၆၈.၇၃ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ